Search Results

Showing results 1 - 10 of 1765.
Sort By: Date ▼

The toughest ethical dilemmas facing doctors in 2018, according to 5,250 physicians

December 10, 2018

Medscape's 2018 Ethics Report unveils doctors' opinions on money, romance with patients, and their most trying ethical dilemmas.

Meet John O'Brien, Azar's new senior adviser on drug pricing

December 10, 2018

John O'Brien, a former executive at CareFirst Blue Cross Blue Shield, will oversee the Trump administration's implementation of a proposed Medicare Part B drug pricing model intended to bring provider reimbursements in line with prices paid in other countries.

Despite 'glimmers of stability,' Moody's predicts worsening financial outlook for nonprofit hospitals

December 10, 2018

Nonprofit hospitals will continue to see expenses outpace revenue in 2019 because of a number of factors, including weak inpatient admissions and increases in bad debt, according to a new report from Moody's Investors Service.

What's behind the slowdown in US health spending? Declining demand, CMS finds.

December 7, 2018

CMS actuaries say U.S. health care spending increased by 3.9% to $3.5 trillion in 2017, down from a growth rate of 4.3% in 2016.

Walgreens partners with FedEx to offer next-day Rx deliveries

December 7, 2018

Under a new partnership with FedEx, Walgreens customers can have their prescriptions delivered to them the next day for $4.99.

CVS to pass on 100% of drug discounts, rebates to PBM clients

December 6, 2018

CVS Health starting Jan. 1, 2019, will offer a new prescription benefit option that will pass on 100% of any discounts or rebates offered by drugmakers to clients that adopt the model.

Incoming Senate Finance Committee leaders unveil bill to address Medicaid drug costs

December 6, 2018

Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), the incoming leaders of the Senate Finance Committee, released a draft bill that would provide HHS with the authority to penalize drugmakers participating in the Medicaid Drug Rebate Program for misclassifying their products.

Why health systems and other providers are trying to make clinical trial enrollment easier

December 3, 2018

A number of health systems, cancer centers, and other providers are coming together to form networks intended to make it easier for pharmaceutical companies to use their facilities—and patients—to conduct clinical trials.

HHS finalizes long-awaited 340B rule

November 30, 2018

HHS has finalized a long-delayed ceiling price and civil monetary penalties rule for Medicare's 340B drug discount program that is slated to take effect Jan. 1, 2019.

Results Page: [Previous] 1 2 3 4 5  ... [Next]